AzTrials
AzTrials

Physical FitnessMUSSCLENCT02661334

Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise

A study testing Creatine Monohydrate and Rice Flour in people with Physical Fitness, run by David Grant U.S. Air Force Medical Center at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the physical fitness performance-as measured by the Air Force Physical Fitness Test (PFT)-of subjects that, in conjunction with exercise, will take creatine supplementation over a four week period versus those that do not. Read more about this study

Who is it for?
Ages 18 to 89 yearsHealthy volunteers can take part
Conditions the study is for
Physical Fitness
What is being tested?
Creatine Monohydrate and Rice Flour
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
6 participants
Where
1 siteUnited States
Study dates
1 Aug 2015to 13 Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male or Female
  • Age ≥18
  • Willing to exercise five days per week for four weeks, performing each component of the AF PFT at least once per week
  • Willing to adhere to a prescribed supplementation regimen, including spaced dosing two times per day
  • Able to meet all study follow-up and testing requirements as outlined in section 6.4 of this protocol

Who cannot join

  • History of:
  • Chronic kidney dysfunction
  • Liver failure
  • Rhabdomyolysis
  • Compartment syndrome
  • Current
Show all 15Show fewer
  • Pregnancy
  • Musculoskeletal injury
  • Fitness exemption from any component of the AF PFT (e.g. AF 469, "profile")
  • Kidney injury
  • Diabetes
  • Hypertension, requiring medication
  • Allergy to rice
  • Admission to the hospital within the past 30 days
  • Creatine supplementation within the past 90 days

Trial locations and contacts

1 site in 1 country.

United States1 site
  • David Grant Medical Center

    Fairfield, California, 94535

Other trials in United States

About this study

Official title: Measuring Uniformed Servicemembers' Fitness Scores on Creatine Loading and Exercise (MUSSCLE)

The purpose of this study is to compare the physical fitness performance-as measured by the Air Force Physical Fitness Test (PFT)-of subjects that, in conjunction with exercise, will take creatine supplementation over a four week period versus those that do not.

Read the detailed description

The purpose of this study is to compare the physical fitness performance-as measured by the Air Force Physical Fitness Test (PFT)-of subjects that, in conjunction with exercise, will take creatine supplementation over a four week period versus those that do not. Based on the literature, there is evidence to support that creatine supplementation may increase available levels of muscle phosphocreatine (PCr), an important energy reservoir that is initially expended with intense muscular contraction and then regenerated during episodes of rest. While mechanistically plausible, the effects of creatine on the specific measures of the PFT (push-ups, sit-ups, 1.5 mile run, and abdominal circumference) have not been evaluated. The target population is Active Duty Air Force (ADAF) service members who perform perform the PFT. As such, this represents a population with occupational requirements to maintain their fitness at a designated level. If short-term creatine supplementation does help to improve PFT scores, trainers, commanders, and unit physicians may wish to consider recommending its use. While generally considered safe, additional data will also be collected to evaluate both the qualitative and quantitative side-effects of creatine supplementation over the study period. If the hypothesis is correct and creatine supplementation is shown to be both effective and safe, additional studies may be warranted to evaluate its impact on ADAF service members who have failed the PFT and/or are at risk of being separated from the AF for unsatisfactory fitness performance. In short, this study has the potential to dramatically affect the recommendations and practices of ADAF service members related to use of creatine supplementation.

Being tested
Creatine Monohydrate, Rice Flour
Keywords
creatine, creatine monohydrate, supplement, exercise, fitness
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creatine MonohydrateDietary supplement

    Creatine monohydrate is a very common supplement used by enthusiasts, athletes, and the general populace

  • Rice FlourDietary supplement

    rice flour powder matched for color, appearance, taste, and solubility

Study groups in NCT02661334
Study groupRoleWhat they receive
PlaceboPlacebo comparator30g white rice flour
Receives: Dietary Supplement: Rice Flour
Low doseExperimental5g/day Creatine Monohydrate (25g white rice flour) for 28 days
Receives: Dietary Supplement: Creatine Monohydrate; Dietary Supplement: Rice Flour
Loading doseExperimentalCreatine Monohydrate 20g/day (10g white rice flour) for 7 days, followed by maintenance dose of Creatine Monohydrate 5g/day (25g white rice flour) for the remaining 21 days
Receives: Dietary Supplement: Creatine Monohydrate; Dietary Supplement: Rice Flour
High doseExperimentalHigh dose of Creatine Monohydrate 20g/day (10g white rice flour) for the entire 28 day period
Receives: Dietary Supplement: Creatine Monohydrate; Dietary Supplement: Rice Flour

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine the effect of creatine supplementation on anaerobic performance in the PFT by measuring change in repetitions of push-ups and sit-ups.

    An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores

    Measured: 28 days

  2. Determine the effect of creatine supplementation on aerobic performance in the PFT by measuring change in 1.5 mile run time.

    An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores

    Measured: 28 days

  3. Determine the effect of creatine supplementation on body composition as it relates to the PFT by measuring change in abdominal circumference

    An initial mock AF PFT will be administered. Individual component raw numbers, scores, and composite scores will be recorded. Participants will self-take their prescribed regimen twice a day, in addition to exercise 5 days/week. Within 7 days of completing the prescribed treatment and exercise course, participants will undergo another mock AF PFT. The individual component raw numbers, scores, and composite scores will be recorded and compared to initial mock scores

    Measured: 28 days

Secondary outcomes (5)
  1. Determine how renal function is affected by creatine supplementation by measuring renal function labs (BUN/Creatinine/GFR-with Cys C) before and after the study period.

    Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw

    Measured: 28 days

  2. Assess for possible liver damage resulting from creatine supplementation by measuring liver function labs (AST/ALT/Alk Phos) before and after the study period.

    Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw

    Measured: 28 days

  3. Evaluate the risk of rhabdomyolysis with creatine supplementation by measuring creatine kinase before and after the study period.

    Labs will be draw before initiation of prescribed treatment. Once the 28-day study period has been completed, each participant will be sent to the DGMC laboratory for a final blood draw

    Measured: 28 days

  4. Treatment compliance as determined by medication diary.

    Participants will be given a log book to record their supplement compliance. They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are appropriately taking their supplements. Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book

    Measured: 28 days

  5. Quality of workout as determined by exercise diary.

    Participants will be given a log book to record their exercise history. They will meet with the study coordinator at the two-week mark (between days 10-14) and review their logbook to ensure they are meeting the requirement of exercising 4 out of 5 days/week. Once the 28-day study period has been completed, each participant with meet with a study team member again to turn in their log book

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2016 (estimated)
  2. Study start1 Aug 2015
  3. Primary completion13 Feb 2018
  4. Study completion13 Feb 2018

Why it stopped: Failure to recruit

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02661334
Sponsor's protocol ID
FDG20150021H
Acronym
MUSSCLE
Status last verified
Apr 2020
First submitted
7 Dec 2015
Last updated
3 Apr 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Creatine Monohydrate and Rice Flour in people with Physical Fitness, run by David Grant U.S. Air Force Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 3 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Failure to recruit). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine the effect of creatine supplementation on anaerobic performance in the PFT by measuring change in repetitions of push-ups and sit-ups. (time frame: 28 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in